<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01195987</url>
  </required_header>
  <id_info>
    <org_study_id>09-290</org_study_id>
    <nct_id>NCT01195987</nct_id>
  </id_info>
  <brief_title>Immune Dysregulation in Hepatitis C Patients With or Without Arthritis</brief_title>
  <official_title>Immune Dysregulation in Hepatitis C Patients With or Without Arthritis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Center for Rheumatic Disease, Allergy, &amp; Immunology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>St. Luke's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>The Center for Rheumatic Disease, Allergy, &amp; Immunology</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to study the role of the Immune System in causing arthritis in
      patients with Hepatitis C.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients will provide one blood sample after qualifying for the study, and signing consent.
      The patients will have a skin test TB, Candida, and Trichophyton placed and will read the
      results themselves and mail back the card with the measurements to be recorded. Labs will
      test for ESR, CBC, CRP, antiCCP, Cryoglobulins, RF, CH50, C3, C4, Flow cytometry, and would
      have already been tested for HIV and Hepatitis C.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 2010</start_date>
  <completion_date type="Anticipated">August 2011</completion_date>
  <primary_completion_date type="Anticipated">August 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Hepatitis C Patients</condition>
  <arm_group>
    <arm_group_label>Hepatitis C with Arthritis</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Hepatitis C without Arthritis</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Hepatitis positive patients with and without osteoarthritis, with a group of Hepatitis C
        negative and no osteoarthritis to serve as controls.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All adults 18 or older, 20 will have hep C positive with a viral load withen 6 mo. of
             enrollment.

          -  Either interferon or antiviral naive or those who failed interferon or antiviral
             therapy more than 6 mo. prior to enrollment.

          -  10 normal healthy controls- Hep C neg and without osteoarthritis (OA).

        Exclusion Criteria:

          -  HIV patients

          -  Those with concomitant alcoholic liver disease

          -  Patients with Rheumatoid Arthritis (RA) or other autoimmune disorders.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nabih I Abdou, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Center for Rheumatic Disease, Allergy &amp; Immunology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nabih I Abdou, MD, PhD</last_name>
    <phone>816-531-0930</phone>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Cindy A Greenwell, RN, BSN, CCRC</last_name>
    <phone>816-531-0930</phone>
    <email>cindy@centerforrheumatic.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Center for Rheumatic Disease, Allergy &amp; Immunology</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64111</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cindy A Greenwell, MD, PHD</last_name>
      <phone>816-531-0930</phone>
      <email>cindy@centerforrheumatic.com</email>
    </contact>
    <investigator>
      <last_name>Nabih I Abdou, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 3, 2010</study_first_submitted>
  <study_first_submitted_qc>September 7, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 8, 2010</study_first_posted>
  <last_update_submitted>September 7, 2010</last_update_submitted>
  <last_update_submitted_qc>September 7, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 8, 2010</last_update_posted>
  <responsible_party>
    <name_title>Dr. Nabih I Abdou, PhD</name_title>
    <organization>Center for Rheumatic Disease, Allergy, &amp; Immunology</organization>
  </responsible_party>
  <keyword>Hepatitis C</keyword>
  <keyword>Arthritis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hepatitis</mesh_term>
    <mesh_term>Hepatitis A</mesh_term>
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Hepatitis C</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

